![Jeremy Graff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeremy Graff
Technik-/Wissenschafts-/F&E-Leiter bei IMV INC.
Vermögen: 5 413 $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
William Ho | M | 48 | 8 Jahre | |
Brittany Davison | F | - | - | |
Michael P. Bailey | M | 58 | 4 Jahre | |
Patrick McCall | M | 41 | 3 Jahre | |
Andrew Hall | M | - | 4 Jahre | |
Lawrence Lamb | M | 70 | 8 Jahre | |
Michael Kalos | M | 62 | 3 Jahre | |
Kate Rochlin | M | 43 | 4 Jahre | |
Delphine Davan | F | - | 5 Jahre | |
Annie Tanguay | F | - | - | |
Linda Barabe | F | - | - | |
Saman Maleki | M | - | 2 Jahre | |
Travis Whitfill | M | 34 | 6 Jahre | |
Markus Warmuth | M | 53 | 6 Jahre | |
Kyle Kuvalanka | M | 56 | 3 Jahre | |
Emily Fairbairn | F | 62 | 3 Jahre | |
Luba Greenwood | F | 45 | 3 Jahre | |
Alan Roemer | M | 54 | 4 Jahre | |
Peter Brandt | M | 67 | 5 Jahre | |
Shabnam Kazmi | F | - | 1 Jahre | |
Jennifer Schmitke | M | - | - | |
Kenneth R. LaMontagne | M | - | 2 Jahre | |
Stacey Bilinski | F | - | 2 Jahre | |
Urvashi Patel | M | - | 2 Jahre | |
Tracy Sherren | F | 58 | - | |
Trishna Goswami | M | 46 | 3 Jahre | |
Ryan Marshall | M | - | 8 Jahre | |
Marie-Eve Charrois | F | - | - | |
Corinne Epperly | M | 46 | 1 Jahre | |
Stéphane Fiset | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Frederic Ors | M | 50 | 6 Jahre | |
Barry A. Labinger | M | 60 |
Biothera Pharmaceutical, Inc.
![]() Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 3 Jahre |
Julia Gregory | F | 71 | 5 Jahre | |
James Hall | M | 79 | 11 Jahre | |
Shermaine Tilley | M | 72 | 7 Jahre | |
Walter Ogier | M | 67 |
Biothera Pharmaceutical, Inc.
![]() Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 6 Jahre |
Pierre Labbé | M | 58 | 5 Jahre | |
Joy Bessenger | F | - | 1 Jahre | |
Michele Gargano | F | - |
Biothera Pharmaceutical, Inc.
![]() Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | - |
Andrew LaFrence | M | 61 |
Biothera Pharmaceutical, Inc.
![]() Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 1 Jahre |
Annalisa Jenkins | M | 58 |
Biothera Pharmaceutical, Inc.
![]() Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 3 Jahre |
Dwight Porter | M | - |
Biothera Pharmaceutical, Inc.
![]() Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 6 Jahre |
Richard Huhn | M | - |
Biothera Pharmaceutical, Inc.
![]() Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | 5 Jahre |
Tariq Massad | M | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Kanada | 23 | 52,27% |
Vereinigte Staaten | 21 | 47,73% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Jeremy Graff
- Persönliches Netzwerk